BSTC - BioSpecifics Technologies Corp.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5474.71M
Enterprise Value 3395.71M
Trailing P/E 20.41
Forward P/E 117.25
PEG Ratio (5 yr expected) 10.91
Price/Sales (ttm)13.09
Price/Book (mrq)4.06
Enterprise Value/Revenue 310.91
Enterprise Value/EBITDA 614.87

Trading Information

Stock Price History

Beta (5Y Monthly) 1.31
52-Week Change 3-6.93%
S&P500 52-Week Change 321.46%
52 Week High 372.83
52 Week Low 345.81
50-Day Moving Average 359.22
200-Day Moving Average 355.59

Share Statistics

Avg Vol (3 month) 343.56k
Avg Vol (10 day) 327.8k
Shares Outstanding 57.34M
Float 4.35M
% Held by Insiders 127.69%
% Held by Institutions 164.11%
Shares Short (Jan 30, 2020) 4293.55k
Short Ratio (Jan 30, 2020) 46.34
Short % of Float (Jan 30, 2020) 44.83%
Short % of Shares Outstanding (Jan 30, 2020) 44.00%
Shares Short (prior month Dec 30, 2019) 4291.59k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Apr 20, 1992

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 64.23%
Operating Margin (ttm)73.22%

Management Effectiveness

Return on Assets (ttm)15.66%
Return on Equity (ttm)22.32%

Income Statement

Revenue (ttm)36.28M
Revenue Per Share (ttm)4.97
Quarterly Revenue Growth (yoy)15.60%
Gross Profit (ttm)32.96M
EBITDA 26.61M
Net Income Avi to Common (ttm)23.3M
Diluted EPS (ttm)3.17
Quarterly Earnings Growth (yoy)24.40%

Balance Sheet

Total Cash (mrq)81.86M
Total Cash Per Share (mrq)11.15
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)115.61
Book Value Per Share (mrq)15.93

Cash Flow Statement

Operating Cash Flow (ttm)19.99M
Levered Free Cash Flow (ttm)13.25M